ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress

January 20, 1989

ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data.

September 26, 2008

Bourne Tells ACCC White House Backs Hospice Concept

May 12, 1978

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010